Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Gene Discoveries Give Hope Against 'Brittle Bone' Disease

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
Scientists pinpoint mutation that appears to cause severe forms of bone loss.

Mutations in a gene involved in bone development appear to cause certain severe forms of bone loss, a finding that could lead to new therapies for the common bone-thinning disorder osteoporosis, researchers report.

The mutations were found in a Swedish family with 10 members affected by a severe, early onset form of osteoporosis, as well as a Hmong family from Laos in which two sisters suffered from osteogenesis imperfecta.

Osteogenesis imperfecta, which is also known as brittle bone disease, affects six to seven out of every 100,000 people worldwide. The disease causes the bones to break easily, often from little or no trauma. There are four main forms, the most severe of which is fatal before or soon after birth.

The most common -- and mildest -- form is Type 1, in which most of a child's bone fractures happen before puberty. Some other problems, such as weak muscles and brittle teeth, are also possible.

Researchers have long known that about 90 percent of osteogenesis imperfecta cases are caused by a single mutation in one of two genes involved in making collagen, a fibrous protein in bone, skin and connective tissue.

It is only in the past decade, though, that the mystery behind the other 10 percent has become clearer, said Dr. Francis Glorieux, chairman of the Osteogenesis Imperfecta Foundation's medical advisory council.

The latest findings, published in the May 9 issue of the New England Journal of Medicine, underscore the role of a gene family known as WNT, said Glorieux, who was not involved in the research.

WNT genes make proteins called ligands, which means they latch onto receptors on the surface of body cells. Scientists have known that WNT is important in bone development and the upkeep of bone mass.

"But we haven't known which protein is key, which WNT ligand is actually doing the work. This study addresses that," said lead researcher Dr. Brendan Lee, a professor of molecular and human genetics at Baylor College of Medicine in Houston.

Specifically, Lee's team found two mutations in the WNT1 gene -- one that caused early onset osteoporosis in the Swedish family, and one that caused a more severe form of osteogenesis imperfecta in the Asian family.

The study is one of four in the past two months alone that have identified various WNT1 mutations in families affected by osteogenesis imperfecta. "It's a hot topic right now," said Glorieux, who worked on one of those studies.

Together, the studies "underscore the importance of this protein in controlling bone formation," Lee said.

Both Lee and Glorieux said studying severe forms of brittle bone disease also gives insight into the common form of osteoporosis that affects many older adults.

In the United States, about 16 percent of women older than 50 have full-blown osteoporosis of the hip or lower spine, as do 4 percent of men, according to the U.S. Centers for Disease Control and Prevention. Many more -- including 61 percent of women -- have lower-than-normal bone mass in those areas.

The hope is to eventually develop new therapies for not only osteogenesis imperfecta, but also osteoporosis, Lee said. Knowing the specific WNT proteins involved in bone formation and maintenance gives researchers targets for new drug development, he explained.

Right now, the most common medications for osteoporosis are bisphosphonates, including brands such as Fosamax, Actonel and Boniva. Those drugs slow bone breakdown; unfortunately, they also put the brakes on bone formation, Lee said.

So researchers are trying to develop medications that would help build bone.

"If we can understand the mechanisms key to developing and maintaining bone mass, that opens potential therapeutic avenues," Glorieux said.

The Swedish family in this study had 10 members affected by a rare, inherited form of early onset osteoporosis, the youngest being a 12-year-old boy. In the Asian family affected by osteogenesis imperfecta, two sisters had severe forms of the disease: One woman was in a wheelchair, less than 3 feet tall and had serious bone deformities; her sister had started suffering fractures while still in the womb, had been paralyzed since early childhood and was severely intellectually impaired.

The sisters had what is known as recessive osteogenesis imperfecta, meaning they inherited a mutated gene from both parents (who were not themselves affected). Most cases of osteogenesis imperfecta arise when a child has just one copy of the defective gene -- either inherited from one parent or because the gene spontaneously mutated.

There is no cure for osteogenesis imperfecta. Right now, treatment involves physical therapy, walking aids, a healthy diet and possibly surgery to place rods through the length of the long bones to strengthen them. Researchers also are studying other treatments, such as growth hormone therapy and IV and oral bisphosphonates.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Combo Tool
Joining molecular components expands ability to manipulate genes in specific cell types.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Genes Associated With Improved Survival for Pancreatic Cancer Patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!